RETRACTED: WORSENING OF PRE-EXISTING VALVULOPATHY WITH A NEW OBESITY DRUG LORCASERIN, A SELECTIVE 5-HYDROXYTRYPTAMINE 2C RECEPTOR AGONIST: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS - Retraction Notice | RetractBase